CSIMarket Company Name, Ticker, Competitors, else..
Lifevantage Corp  (NASDAQ: LFVN)
Other Ticker:  
 


 

Lifevantage Corp

LFVN's Financial Statements and Analysis



Lifevantage Corp reported in the first quarter of 2026 net earnings per share of $0.17 an increase by 21.43 % year on year from $0.14 and an improvement of 12.47 % from $0.15 realized in IV. Quarter (Jun 30 2025).


first quarter of 2026
Earnings Per Share Revenues
$ 0.17 $  47 Mill
$+0.03     +21.43 % Unch.     +0.2 %



Lifevantage's Revenue rose by 0.2 % in first quarter of 2026 (Sep 30 2025) year on year, to $47 million and declined by -14.96 % sequentially.


Lifevantage is

More on LFVN's Income Statement



Lifevantage 's net income of $2.155 million in the first quarter of 2026 increased by 18.02 % from net earnings of $1.826 million achieved in I. Quarter a year ago.

Sequentially net earnings grew by 10.01 % from net income of $1.959 million realized in previous quarter.

More on LFVN's Growth

Lifevantage Inventories
Inventories grew by 21.76 % to $21 million from I. Quarter a year ago, sequentially inventories fell by -0.36 %. In Sep 30 2025 company's net cash and cash equivalents decreased by $-7 million, capital expenditures fell by -0.34925.79%, to $0 millions compare to same quarter a year ago

More on LFVN's Cash flow Statement


Lifevantage Corp payed out dividend of $0.16 per share in last 52 weeks representing 20.78 % of net earning per share in trailing twelve-month period.

During the same period Lifevantage Corp earned $ 0.78 cash per share, on a free-cash flow basis 101.88 % of net earning per share.

Book value fell by -3.34 % sequentially to $2.56 per share.
Tangible Book value fell to $ 2.54 per share from $ 2.63.

Company repurchased 0.13 million shares or 0.97 % in Sep 30 2025.
Interest Coverage Ratio was 18.82.

• More on LFVN's Dividends

 Market Capitalization (Millions) 86
 Shares Outstanding (Millions) 13
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 228
 Net Income (TTM) (Millions $) 10
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0.16 $
 Dividend Yield TTM (%) 2.72 %
 Employees (TTM) $ 222




Lifevantage Corp payed out dividend of $0.16 per share in the last 52 weeks representing 20.78 % of net earning per share in trailing twelve-month period.

During the same period Lifevantage Corp had $ 0.78 cash flow per share, on a free-cash flow basis 101.88 % of net earning per share.

Book value fell by -3.34 % sequentially to $2.56 per share.
Tangible Book value fell to $ 2.54 per share from $ 2.63.

Company repurchased 0.13 million shares or 0.97 % in Sep 30 2025.
Interest Coverage Ratio was 18.82.

• More on LFVN's Balance Sheets

 Market Capitalization (Millions) 86
 Shares Outstanding (Millions) 13
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) 228
 Net Income (TTM) (Millions $) 10
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -1
 Dividend TTM ($) 0.16 $
 Dividend Yield TTM (%) 2.72 %
 Employees (TTM) $ 222
   


  News about Lifevantage Corp Earnings

Lifevantage Corp's Q2 2024 Revenue Plunges by -3.921%: What's Next for this Leading Health and Wellness Company?

LifeVantage Corporation, a leading health and wellness company, recently announced its financial results for the second fiscal quarter, ending December 31, 2023. Despite reporting a loss of $0.05 per share, it is important to note that this is an improvement compared to a loss of $0.08 per share in the same period the previous year. Additionally, the company's income per share fell from $0.05 in the preceding quarter, highlighting the need for further analysis.
On the revenue front, LifeVantage witnessed a 3.921% contraction to $51.56 million from $53.66 million in the corresponding quarter of the previous year. However, when comparing sequentially, there was a growth of 0.731% from $51.18 million. While...

Revitalized Growth: Lifevantage Corp?s Remarkable Journey from July to September 20232.

Lifevantage Corp Announces Stable Earnings Per Share Despite Modest Revenue Decline
Lifevantage Corp, a major pharmaceutical preparations company, has recently released its financial results for the interval ending September 30, 2023. The company reported earning per share (EPS) of $0.05, remaining unscathed compared to the previous year. However, there was a modest decline in revenue, with a decrease of -1.14% to $51.18 million year on year. The EPS and revenue figures represent a decline from the preceding quarter, where EPS was at $0.16 per share and revenue decreased by -4.923% to $53.83 million.
Despite the decline in revenue, Lifevantage Corp showed a positive bottom line. The company achieved ...

Lifevantage Corp Shines Bright in Fourth Quarter Earnings Season - Experiencing a Phenomenal 94.84% Surge in EPS and Turnaround from Losses to Massive Profits!

Lifevantage Corp, a major player in the Major Pharmaceutical Preparations sector, has recently ...

Lifevantage Corp's Income Takes a Hit, But Revenue Sees Steady Growth

Lifevantage Corp, a company in the Major Pharmaceutical Preparations industry, recently announced its second-quarter earnings for 2023. The company reported EPS of $0.08 and revenue of $53.66 million for the quarter. While this is an increase in revenue by 7.473% from the same period a year prior, the company's income fell by $0.01 per share from $0.09 EPS in the previous year.
Despite the decline in income, Lifevantage Corp saw its EPS turn positive from -$0.08 per share, and the Q2 revenue increased slightly by 0.147% from $53.66 million. However, the bottom-line of $1.022 million in the fiscal year closing on March 31, 2023, fell by 10.43% from $1.141 million in the corresponding period a year before....


Date modified: 2025-11-11T18:42:54+00:00




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.